Genzyme is to build a new production site at its European centre in Haverhill, near Cambridge.
The US company will produce Renagel, a kidney failure treatment.
Financial Times 02/02/01 page 5
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
